National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 25254-25255 [E9-12242]
Download as PDF
<![CDATA[
erowe on PROD1PC63 with NOTICES
25254
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; Molecular
and Cellular Processes of Neurodegeneration.
Date: June 12, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Laurent Taupenot, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; Bacterial
and Host Defenses.
Date: June 12, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Georgetown Suites, 1111 30th Street,
NW., Washington, DC 20007.
Contact Person: Fouad A. El-Zaatari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7808, Bethesda, MD 20814–9692, (301)
435–1149, elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; ARRA
Competive Revision Application Review.
Date: June 12, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel Chicago, 701
North Michigan Avenue, Chicago, IL 60611.
Contact Person: Jin Huang, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4095G, MSC 7812, Bethesda,
MD 20892, 301–435–1230, jh377p@nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; Member
Conflicts-Psychosocial Development, Risk,
and Prevention.
Date: June 12, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Karen Lechter, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3128,
MSC 7759, Bethesda, MD 20892, 301–496–
0726, lechterk@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; MESH:
Review of Competing Revisions.
Date: June 12, 2009.
Time: 5 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Warwick Seattle Hotel, 401 Lenora
Street, Seattle, WA 98121.
Contact Person: Maribeth Champoux, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
VerDate Nov<24>2008
15:23 May 26, 2009
Jkt 217001
MSC 7848, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; Family
Planning Service Delivery Improvement
Research.
Date: June 12, 2009.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Estina E. Thompson, PhD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–496–
5749, thompsone@mail.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; Cell
Biology Member SEP.
Date: June 12, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Jonathan Arias, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840, Bethesda, MD 20892, 301–435–
2406, ariasj@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel;
Competitive Revisions: Clinical
Neuroimmunology and Brain Tumors.
Date: June 12, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue, NW., Washington, DC 20037.
Contact Person: Jay Joshi, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5196, MSC 7846, Bethesda, MD
20892, (301) 435–1184, joshij@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Electrical Signaling, Ion Transport,
and Arrhythmias Study Section.
Date: June 14–15, 2009.
Time: 7 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin St. Francis, 335 Powell
Street, San Francisco, CA 94102.
Contact Person: Rajiv Kumar, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7802, Bethesda, MD 20892, 301–435–
1212, kumarra@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Dated: May 19, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–12244 Filed 5–26–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Cardiac Development Consortium.
Date: June 16, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Tony L. Creazzo, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180,
Bethesda, MD 20892–7924, 301–435–0725,
creazzot@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Patient Oriented Research (K23, 24, and 25’s)
Career Enhancement Awards.
Date: June 16–17, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott, 1999 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Mark Roltsch, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7192,
Bethesda, MD 20892–7924, 301–435–0287,
roltschm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Pediatric Translational Consortium
Administrative Coordinating Center.
Date: June 16, 2009.
Time: 5 p.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27MYN1.SGM
27MYN1
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Tony L. Creazzo, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180,
Bethesda, MD 20892–7924, 301–435–0725,
creazzot@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Pediatric Cardiac Genomics
Consortium.
Date: June 17, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Tony L. Creazzo, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7180,
Bethesda, MD 20892–7924, 301–435–0725,
creazzot@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 19, 2009
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–12242 Filed 5–26–09; 8:45 am]
Date: May 27, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: Presentations and discussions
regarding revisions to the draft NSABB report
on Enhancing Personnel Reliability among
Individuals with Access to Select Agents and
Toxins.
Place: National Institutes of Health, Office
of Biotechnology Activities, Suite 750,
Bethesda, Maryland 20892. (Telephone
Conference Call).
Call-in Information: Toll-Free Number: 1–
800–988–9458. Participant Passcode:
NSABB.
Contact Person: Ronna Hill, NSABB
Program Assistant, 6705 Rockledge Drive,
Bethesda, Maryland 20892. (301) 496–9838.
The teleconference meeting agenda,
revised draft report and other information
about the NSABB will be available at
https://www.biosecurityboard.gov Please
check this Web site for updates.
The teleconference will include
opportunity for public comment. In addition,
any interested person may file written
comments with the committee. All written
comments must be received by May 26, 2009
and should be sent via e-mail to
nsabb@od.nih.gov with ‘‘NSABB Public
Comment’’ as the subject line or by regular
mail to 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892, Attention: Ronna Hill.
The statement should include the name,
address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
This notice is being published less than 15
days prior to the meeting due to time
restraints placed on Committee deliberations.
Dated: May 18, 2009.
Jennifer Spaeth,
Office of Federal Advisory Committee Policy.
[FR Doc. E9–12275 Filed 5–26–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
erowe on PROD1PC63 with NOTICES
Office of Biotechnology Activities,
Office of Science Policy, Office of the
Director; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a public
teleconference of the National Science
Advisory Board for Biosecurity
(NSABB).
Under authority 42 U.S.C. 217a,
section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
NSABB to provide advice, guidance and
leadership regarding Federal oversight
of dual use research, defined as
biological research with legitimate
scientific purposes that could be
misused to pose a biological threat to
public health and/or national security.
A publicly accessible teleconference
line will be available for the meeting.
Name of Committee: National Science
Advisory Board for Biosecurity.
VerDate Nov<24>2008
15:23 May 26, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
25255
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: June 13–14, 2009.
Open: June 13, 2009, 5:30 p.m. to 6 p.m.
Agenda: To review procedures and discuss
policy.
Place: Four Points Sheraton, 1201 K Street,
NW., Washington, DC 20005.
Closed: June 13, 2009, 6:00 p.m. to 9:30
p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Points Sheraton, 1201 K Street,
NW., Washington, DC 20005.
Closed: June 14, 2009, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Points Sheraton, 1201 K Street,
NW., Washington, DC 20005.
Contact Person: John F. Connaughton, PhD,
Chief, Chartered Committees Section, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7797,
connaughtonj@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee.
Date: June 17–18, 2009.
Open: June 17, 2009, 8 a.m. to 8:30 a.m.
Agenda: To review procedures and discuss
policy.
Place: Georgetown Suites, 1000 29th Street
NW., Washington, DC 20007.
Closed: June 17, 2009, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Georgetown Suites, 1000 29th Street
NW., Washington, DC 20007.
Closed: June 18, 2009, 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Georgetown Suites, 1000 29th Street,
NW., Washington, DC 20007.
Contact Person: Dan E. Matsumoto, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
matsumotod@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: June 24–25, 2009.
Open: June 24, 2009, 8 a.m. to 8:30 a.m.
Agenda: To review procedures and discuss
policy.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
E:\FR\FM\27MYN1.SGM
27MYN1
]]>Agencies
[Federal Register Volume 74, Number 100 (Wednesday, May 27, 2009)]
[Notices]
[Pages 25254-25255]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12242]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, NHLBI Cardiac Development Consortium.
Date: June 16, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Tony L. Creazzo, PhD, Scientific Review Officer,
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7180, Bethesda, MD 20892-7924, 301-435-0725,
creazzot@mail.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Patient Oriented Research (K23, 24, and
25's) Career Enhancement Awards.
Date: June 16-17, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Crystal City Marriott, 1999 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: Mark Roltsch, PhD, Scientific Review Officer,
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7192, Bethesda, MD 20892-7924, 301-435-0287,
roltschm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, NHLBI Pediatric Translational Consortium
Administrative Coordinating Center.
Date: June 16, 2009.
Time: 5 p.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
[[Page 25255]]
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Tony L. Creazzo, PhD, Scientific Review Officer,
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7180, Bethesda, MD 20892-7924, 301-435-0725,
creazzot@mail.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, NHLBI Pediatric Cardiac Genomics Consortium.
Date: June 17, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Tony L. Creazzo, PhD, Scientific Review Officer,
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7180, Bethesda, MD 20892-7924, 301-435-0725,
creazzot@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 19, 2009
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-12242 Filed 5-26-09; 8:45 am]
BILLING CODE 4140-01-P
